TAZAROTENE
Generic: TAZAROTENE
Padagis Israel Pharmaceuticals LtdManufacturer
TOPICALRoute
TAZAROTENEActive Substance
2023-04-25Original Approval
TAZAROTENE is FDA application ANDA213079, sponsored by PADAGIS ISRAEL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
45 reports
2
OFF LABEL USE
32 reports
3
HEADACHE
16 reports
4
NAUSEA
16 reports
5
PSORIASIS
14 reports
6
DIARRHOEA
13 reports
7
PRODUCT USE IN UNAPPROVED INDICATION
13 reports
8
APPLICATION SITE DISCOLOURATION
12 reports
9
VOMITING
11 reports
10
PAIN
10 reports